FIANOSTICS combines scientific and technical expertise in diagnostics with the development of a high-tech detection platform. We develop, produce and distribute highly sensitive Metal Enhanced Fluorescence based immunoassays for routine diagnostics (IVD) and clinical research (RUO). Development and production are carried out in accordance with the current ISO 13485 and IVDR. All assays are designed as open systems and can be used on any fluorescence microplate reader. We also offer contract development for immunoassays or transfer of existing assays to our MEF platform.
Company Details
- Employees
- 4
- Address
- Viktor Kaplan Strasse 2, Objekt E,2. Og,austria
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.fianostics.at/
- Keywords
- Wiener Neustadt.
- HQ
- Wiener Neustadt, Niederösterreich
Fianostics Questions
Fianostics's website is https://www.fianostics.at/
Fianostics's LinkedIn profile is https://at.linkedin.com/company/fianostics
Fianostics has
4 employees.
View email and phone details for 4
employees at Fianostics.
Fianostics's industry is
Research Services
Fianostics's top competitors are
Dipromed,
Sanochemia Pharmazeutika,
Stryker,
Fmb Care Gmbh,
Inoolab,
International Chair In Bioethics (Icb),
Stratec Se,
Eu-Openscreen,
Labraum Gmbh,
Drive-Health.
Fianostics's categories are Research Services
